BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38083206)

  • 1. Multi-task Model for Glioma Segmentation and Isocitrate Dehydrogenase Status Prediction Using Global and Local Features.
    Shi X; Li Y; Cheng J; Bai J; Zhao G; Chen YW
    Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-5. PubMed ID: 38083206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Intra- and Inter-Modality Fusion Model Using MR Images for Prediction of Glioma Isocitrate Dehydrogenase (IDH) Mutation.
    Shi X; Zhang X; Iwamoto Y; Cheng J; Bai J; Zhao G; Chen YW
    Annu Int Conf IEEE Eng Med Biol Soc; 2022 Jul; 2022():198-202. PubMed ID: 36086447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
    Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
    Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multimodal domain adaptive segmentation framework for IDH genotype prediction.
    Zeng H; Xing Z; Gao F; Wu Z; Huang W; Su Y; Chen Z; Cai S; Cao D; Cai C
    Int J Comput Assist Radiol Surg; 2022 Oct; 17(10):1923-1931. PubMed ID: 35794409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Fully Automated Multimodal MRI-Based Multi-Task Learning for Glioma Segmentation and IDH Genotyping.
    Cheng J; Liu J; Kuang H; Wang J
    IEEE Trans Med Imaging; 2022 Jun; 41(6):1520-1532. PubMed ID: 35020590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas.
    Zhou H; Chang K; Bai HX; Xiao B; Su C; Bi WL; Zhang PJ; Senders JT; Vallières M; Kavouridis VK; Boaro A; Arnaout O; Yang L; Huang RY
    J Neurooncol; 2019 Apr; 142(2):299-307. PubMed ID: 30661193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep wavelet scattering orthogonal fusion network for glioma IDH mutation status prediction.
    Chen Q; Wang L; Xing Z; Wang L; Hu X; Wang R; Zhu YM
    Comput Biol Med; 2023 Nov; 166():107493. PubMed ID: 37774558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated MRI based pipeline for segmentation and prediction of grade, IDH mutation and 1p19q co-deletion in glioma.
    Decuyper M; Bonte S; Deblaere K; Van Holen R
    Comput Med Imaging Graph; 2021 Mar; 88():101831. PubMed ID: 33482430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. World Health Organization Grade II/III Glioma Molecular Status: Prediction by MRI Morphologic Features and Apparent Diffusion Coefficient.
    Maynard J; Okuchi S; Wastling S; Busaidi AA; Almossawi O; Mbatha W; Brandner S; Jaunmuktane Z; Koc AM; Mancini L; Jäger R; Thust S
    Radiology; 2020 Jul; 296(1):111-121. PubMed ID: 32315266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel fully automated MRI-based deep-learning method for classification of IDH mutation status in brain gliomas.
    Bangalore Yogananda CG; Shah BR; Vejdani-Jahromi M; Nalawade SS; Murugesan GK; Yu FF; Pinho MC; Wagner BC; Mickey B; Patel TR; Fei B; Madhuranthakam AJ; Maldjian JA
    Neuro Oncol; 2020 Mar; 22(3):402-411. PubMed ID: 31637430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined molecular subtyping, grading, and segmentation of glioma using multi-task deep learning.
    van der Voort SR; Incekara F; Wijnenga MMJ; Kapsas G; Gahrmann R; Schouten JW; Nandoe Tewarie R; Lycklama GJ; De Witt Hamer PC; Eijgelaar RS; French PJ; Dubbink HJ; Vincent AJPE; Niessen WJ; van den Bent MJ; Smits M; Klein S
    Neuro Oncol; 2023 Feb; 25(2):279-289. PubMed ID: 35788352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging criteria for prediction of isocitrate dehydrogenase (IDH) mutation status in patients with grade II-III astrocytoma and oligodendroglioma.
    Çelik S; Öven BB; Demir MK; Yılmaz EÇ; Kanan D; Özdamarlar U; Emirzeoglu L; Yapıcıer Ö; Kılıç T
    Clin Neurol Neurosurg; 2021 Aug; 207():106745. PubMed ID: 34146841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isocitrate dehydrogenase (IDH) status prediction in histopathology images of gliomas using deep learning.
    Liu S; Shah Z; Sav A; Russo C; Berkovsky S; Qian Y; Coiera E; Di Ieva A
    Sci Rep; 2020 May; 10(1):7733. PubMed ID: 32382048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive assessment of isocitrate dehydrogenase mutation status in cerebral gliomas by magnetic resonance spectroscopy in a clinical setting.
    Tietze A; Choi C; Mickey B; Maher EA; Parm Ulhøi B; Sangill R; Lassen-Ramshad Y; Lukacova S; Østergaard L; von Oettingen G
    J Neurosurg; 2018 Feb; 128(2):391-398. PubMed ID: 28298040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Pathology for Prediction of Isocitrate Dehydrogenase Gene Mutation from Whole Slide Images in Adult Patients with Diffuse Glioma.
    Zhao Y; Wang W; Ji Y; Guo Y; Duan J; Liu X; Yan D; Liang D; Li W; Zhang Z; Li ZC
    Am J Pathol; 2024 May; 194(5):747-758. PubMed ID: 38325551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics.
    Choi YS; Bae S; Chang JH; Kang SG; Kim SH; Kim J; Rim TH; Choi SH; Jain R; Lee SK
    Neuro Oncol; 2021 Feb; 23(2):304-313. PubMed ID: 32706862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of IDH genotype in gliomas with dynamic susceptibility contrast perfusion MR imaging using an explainable recurrent neural network.
    Choi KS; Choi SH; Jeong B
    Neuro Oncol; 2019 Sep; 21(9):1197-1209. PubMed ID: 31127834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating between glioblastomas with and without isocitrate dehydrogenase gene mutation by findings on conventional magnetic resonance images.
    Shimizu T; Matsushima S; Fukasawa N; Akasaki Y; Mori R; Ojiri H
    J Clin Neurosci; 2020 Jun; 76():140-144. PubMed ID: 32291242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of IDH and TERTp mutations using dynamic susceptibility contrast MRI with deep learning in 162 gliomas.
    Buz-Yalug B; Turhan G; Cetin AI; Dindar SS; Danyeli AE; Yakicier C; Pamir MN; Özduman K; Dincer A; Ozturk-Isik E
    Eur J Radiol; 2024 Jan; 170():111257. PubMed ID: 38134710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas.
    Hong EK; Choi SH; Shin DJ; Jo SW; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SH; Won JK; Kim TM; Park CK; Kim IH; Lee ST
    Korean J Radiol; 2021 Feb; 22(2):233-242. PubMed ID: 32932560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.